Hepatocyte nuclear factor 1a (HNF1a) is a liver-enriched transcription factor that is critical for the maintenance of hepatocyte function. Our previous studies have demonstrated the therapeutic effects of HNF1a on hepatic fibrosis and hepatocellular carcinoma (HCC) in animals. In this study, we created hepatocyte-specific Hnf1a knockout mice using the Cre-loxP recombination system. The knockout mice display increased fatty acid synthesis in the liver. Moreover, these mice spontaneously develop HCC through fatty liver without cirrhosis. Inflammatory cytokines, such as tumor necrosis factor a and IL-6, are upregulated and accompanied by increased phosphorylation of Akt, p-65 and STAT3 in the livers of HNF1a knockout mice. Our findings suggest that HNF1a plays a crucial role in hepatocyte lipid metabolism and hepatocarcinogenesis.
Hepatocellular carcinoma (HCC) is the most common type of liver cancer [1] . Although chronic hepatitis including viral infections (hepatitis B or C) and chronic alcohol consumption are the most prevalent risk factors for hepatocarcinogenesis, nonalcoholic fatty liver disease (NAFLD) is also considered as the evolving cause of HCC [2, 3] . A recent clinical study revealed that diagnosis of NAFLD-related HCC (NAFLD-HCC) was often delayed compared to hepatitis C virus-related HCC, resulting in worse prognosis [4] . NAFLD is a common liver disorder characterized by excessive deposition of fat in hepatocytes without heavy alcohol consumption or other etiologies. Nonalcoholic steatohepatitis (NASH) is the progressive subtype of NAFLD [5] . At present, the 'multiple parallel hits' theory of NAFLD pathogenesis has been widely accepted. Genetic differences, insulin resistance, and intestinal microbiota are considered multiple Abbreviations ALT, alanine aminotransferase; APOA2, Apolipoprotein A2; CHO-C3, total cholesterol; CYPs, cytochrome P450s; Gpc-3, glypican-3; HCC, hepatocellular carcinoma; HFD, high-fat diet; HNF1a, hepatocyte nuclear factor 1a; IL-6, interleukin-6; IPGTT, intraperitoneal glucose tolerance test; LDL, LDL-cholesterol; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; NAS, NAFLD activity score; NF-jB, nuclear factor kappa-light-chain-enhancer of activated B cells; STAT3, signal transducer and activator of transcription; TGFb1, transforming growth factor b1; TNFa, tumor necrosis factor a; a-SMA, a-smooth muscle actin.
parallel hits, which induce adipokine secretion and endoplasmic reticulum and oxidative stress, resulting in hepatic steatosis, inflammation, and fibrosis [6] . However, the causal relationship between NAFLD and HCC is not fully understood, due to the difficulty in following liver histology changes in NAFLD patients.
Hepatocyte nuclear factor 1a (HNF1a), a member of the HNF1 subfamily, contains a Pit-Oct-Unc-homeodomain binding to DNA as a homodimer [7] . HNF1a is enriched in the liver and is also present in the pancreas, kidneys, intestine, and stomach [8] . As a transcriptional activator, HNF1a regulates the expression of multiple genes in the liver [9, 10] . Previous studies demonstrated that mice with complete Hnf1a knockout have hyperglycemia, hypercholesterolemia, and decreased hepatocyte bile acid storage protein, through changes of cytochrome P450s, indicating an important relationship between liver function and HNF1a [11, 12] . A recent study revealed that HNF1a mutation increases lipogenesis by promoting fatty acid synthesis and downregulating expression of liver fatty acid-binding protein 1 (L-FABP) [13] . However, all these studies were performed in mice with whole body Hnf1a knockout. To investigate the exact effects of HNF1a on liver function, a mouse model with hepatocyte-specific knockout of Hnf1a is required.
Our previous studies revealed a significant reduction of HNF1a in fibrotic liver and HCC tissue [14, 15] . Upregulation of HNF1a significantly alleviated liver fibrosis, and impeded the growth of HCC xenografts in mice [14, 15] . However, it remains unclear whether HNF1a plays a role in NAFLD-HCC. In this study, we have established a hepatocyte-specific Hnf1a knockout mouse model to examine the role of HNF1a in NAFLD-HCC.
Materials and methods

NAFLD animal model
Male C57BL/6J mice (6 weeks old, weighing approximately 20 g, from the Shanghai Experimental Center of the Chinese Academy of Sciences) were housed in standard animal laboratory conditions in the experimental animal center of Second Military Medical University. After 1 week of acclimatization, the mice were randomly separated into two groups; one was fed standard chow, the other a high-fat (HF) diet composed of 42% fat, 15% protein, and 43% carbohydrate (Trophic Animal Feed High-Tech Company, Nantong, China). After 30 weeks, four animals in each group were sacrificed. All animal experiments were approved by the Scientific Investigation Board of Second Military Medical University.
Histological analysis and immunohistochemistry (IHC)
Liver, pancreas, intestine, and kidney tissues were fixed in formalin and paraformaldehyde for paraffin sections and frozen sections, respectively. Hematoxylin and eosin (H&E) staining was used for general morphological observations. Sirius red staining and oil red O staining were used for collagen and steatosis detection, respectively. Histology was evaluated using the NAFLD activity score (NAS) designed and validated by the NASH-Clinical Research Network [16, 17] . An expert pathologist who was blinded to this study assessed liver histology. The intensity of collagen deposition was calculated as the percentage of the positive area of Sirius red staining in the corresponding field of liver tissue by using image analysis software (IMAGE-PRO Plus 6.0; Media Cybernetics, Rockville, MD, USA).
The primary antibodies used in IHC included HNF1a (ab96777; Abcam, Cambridge, UK), a-smooth muscle actin (a-SMA; ab5694; Abcam), glypican-3 (Gpc3; ab186872, Abcam), Ki-67 (ab16667; Abcam), tumor necrosis factor a (TNFa; BA0131; Boster, Wuhan, China), transforming growth factor b1 (TGFb1; BA0290, Boster), and interleukin-6 (IL-6; sc-1265; Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Quantitative real-time PCR
Total RNA was extracted from cells and tissues with TRIzol (Invitrogen, Carlsbad, CA, USA). Transcript levels were detected via real-time reverse transcription polymerase chain reaction (RT-PCR) with a SYBR Green PCR Kit (Takara, Tokyo, Japan). Primers are listed in Table S1 .
Western blot analysis
Tissues and cells were lysed in lysis buffer (pH 6.8 tris HCl, 100% glyceryl, 20% SDS). Lysates were separated on 8% sodium dodecyl sulfate-polyacrylamide gels and transferred to methanol-activated nitrocellulose membranes (HAHY00010; Millipore, Merck KGaA, Darmstadt, Germany). Membranes were blocked in PBS containing 1% Tween-20 and 5% milk for 1 h and incubated with primary antibodies overnight at 4°C. After 1 h of incubation with donkey anti-mouse or donkey anti-rabbit secondary antibodies (IRDye 800; LI-COR Biosciences, Lincoln, NE, USA), signals were imaged using an Odyssey infrared imaging system (LI-COR Biosciences) at a wavelength of 800 nm. Primary antibodies used were HNF1a (ab96777; Abcam), collagen I (BA0325; Boster), a-SMA (ab5694; Abcam), phospho-signal transducer and activator of transcription 3 (STAT3; 9145S; Cell Signaling Technologies), STAT3 (4909S; Cell Signaling Technologies), phospho-nuclear factor j-light-chain-enhancer of activated B cells (NF-jB) subunit p65 (3033S; Cell Signaling Technologies), p65 (8242S; Cell Signaling Technologies), phospho-Akt (4056S; Cell Signaling Technologies), Akt (4691P; Cell Signaling Technologies), and GAPDH (BSAP0063; Bioworld).
Targeting vector and generation of Hnf1a
H-KO mice Hnf1a conditional knockout mice were generated by Shanghai Model Organisms Center, Inc. (Shanghai, China). To generate the Hnf1a targeting vector, genomic fragments of Hnf1a were obtained from the RP23-389i14 BAC clone [18] . A loxP site and a Frt-Pgk-Neo-polyAFrt cassette were introduced into the second intron of Hnf1a, and a second loxP site was induced to the third intron. Cre-mediated recombination at the loxP sites resulted in deletion of the third exon, causing a frameshift mutation and a premature stop codon in exon 4. The linearized targeting vector was introduced into SCR012 embryonic stem cells by electroporation, and G418-resistant clones were screened for homologous recombination by PCR analysis. Targeted embryonic stem cell clones were microinjected into eight-cell stage ICR embryos and transferred into pseudopregnant ICR females. The resulting chimeras were bred with C57BL/6 mice, and heterozygous offspring were identified by PCR. Heterozygous mice were mated with EIIa-Flp transgenic mice to generate Hnf1a-flox (Hnf1a f/f ) mice. Hnf1a f/f mice were mated with Alb-Cre transgenic mice to generated Hnf1a H-KO mice. Knockout mice were identified by PCR. The primers were listed in Table S1 .
Intraperitoneal glucose tolerance test
To evaluate insulin resistance in Hnf1a H-KO mice, a glucose tolerance test was performed after 12 h of fasting. The glucose concentrations were measured in blood collected from the tail vein immediately before and 30, 60, 90, and 120 min after intraperitoneal injection of a bolus of glucose (0.75 gÁkg À1 ). Plasma glucose concentrations were measured with an ACCU-CHEK Glucometer (Roche, Basel, Switzerland).
Biochemical assays
Serum biochemical parameters were measured with an automated analyzer in the Clinical Immunology department in Eastern Hepatobiliary Surgery Institute.
Cell isolation
A two-step collagenase procedure was used to isolated primary hepatocytes from male Hnf-1a H-KO mice, as previously described [19] .
Statistical analyses
All the data are given as mean AE standard error of the mean (SEM). Comparisons between two groups were assessed using a two-tailed unpaired t-test for independent samples. A P value <0.05 was considered statistically significant.
Results
Decreased expression of HNF1a in the livers of NAFLD mice An NAFLD animal model was established by feeding mice a HF diet. H&E and oil red O staining after 30 weeks displayed enhanced liver steatosis and inflammatory factor infiltration in the HF group (Fig. 1A) . Sirius red staining, IHC, western blot, and real-time PCR demonstrated the formation of collagen deposits and enhanced expression of a-SMA (Fig. 1A-C) . Taken together, these results indicated that an NAFLD model was successfully established. Interestingly, the expression of HNF1a was decreased in the NAFLD model, as indicated by IHC, real-time PCR, and western blot.
Generation of Hnf1a H-KO mice
To investigate the role of HNF1a in NAFLD, Hnf1a H-KO mice were generated by conditional gene knockout. As shown in Fig. 2A , an Hnf1a gene targeting vector was constructed. A loxP-Pgk.Neo cassette and the second loxP site were inserted to the intron of both side of the third exon. Cre-mediated recombination at the two loxP sites resulted in deletion of the floxed region, resulting in a frameshift mutation and premature stop codon in exon 4. As a result, the expression of HNF1a in the liver of 10-week-old Hnf1a H-KO mice was significantly reduced compared to littermate control mice, while the expression of HNF1a was not altered in other organs, including the pancreas, intestine, and kidney (Fig. 2B) . Real-time PCR and western blot confirmed the IHC results (Fig. 2C,D) , suggesting that HNF1a is specifically deleted in the hepatocytes of Hnf1a H-KO mice.
Hnf-1a H-KO mice develop fatty liver, NASH, and spontaneous HCC The livers of Hnf1a H-KO mice at different ages were analyzed to examine the role of HNF1a in the liver. At both 10 and 30 weeks, the livers had pale yellow color and coarse surfaces. Interestingly, multiple large tumor nodules were detected in the livers of 70-week-old Hnf1a H-KO mice, while none were detected in their normal littermates (Fig. 3A) . Microscopic observation indicated that 54.5% (6/11 mice) of male and 42.9% (3/7 mice) of female Hnf1a H-KO mice displayed tumor nodules in their livers (Fig. 3B) .
Hematoxylin and eosin and oil red O staining indicated that the hepatocytes of 10-week-old Hnf1a H-KO mice were filled with multiple small fat droplets (Fig. 3C) . Hepatocyte ballooning degeneration and inflammatory cell infiltration also appeared by 30 weeks (Fig. 3D) , and the NAS of 30-week-old Hnf1a H-KO mice reached the diagnostic criteria of NASH. Compared with steatosis, the change in ballooning and lobular inflammation plays a major role in process of fatty liver to NASH in this model (Fig. 3E) . Additionally, increased collagen deposition accompanied by a-SMA staining was detected in the livers of 30-week-old knockout mice (Fig. 3C) . This indicates that deficiency of HNF1a in hepatocytes results in NASH accompanied by hepatic fibrosis. However, there was no significant difference in the sirius red-positive area between 30-and 70-week-old Hnf1a H-KO mice (Fig. 3F ). In addition, no pseudolobuli appeared in the livers even at 70 weeks (Fig. 3G) , suggesting that no cirrhosis was established in this model. Tumor nodules in the livers of 70-week-old mice resembled well-differentiated HCC, characterized by thickened cell plates, loss of cellular reticulin fibers, severe dysplasia, and increased nuclear-cytoplasmic ratio. Many tumor cells had clear cytoplasm that was not stained by H&E, because of the cytoplasmic accumulation of large amounts of lipid. As welldifferentiated HCC has overlapping morphologic features with hepatocellular adenoma (HCA) [20] , we further investigated the tumor type in Hnf1a H-KO mice by immunohistochemical staining of glypican-3 (Gpc3), an early diagnosis marker of HCC [21] , and observed significant Gpc3 signal in the cytoplasm of tumor cells (Fig. 3G) . Moreover, Ki-67-positive cells were observed within the tumor lesions, indicating that the tumor cells were in a proliferative state [22] ( Fig. 3G) .
Hnf1a H-KO mice exhibit increased fatty acid synthesis
The liver weight to body weight ratio was higher in Hnf1a H-KO mice compared with their normal 10-and mice was analyzed by IHC. n = 4-6 mouse in each group.*P < 0.05; **P < 0.01.
30-week-old littermates. Similarly, alanine aminotransferase was increased in Hnf1a H-KO mice at these ages (Fig. 4A) , indicating that liver injury occurred with Hnf1a knockout. Moreover, dyslipidemia was observed in Hnf1a H-KO mice, with increased total and low-density lipoprotein cholesterol (Fig. 4B) , and blood glucose regulation was impaired, suggesting Hnf1a H-KO mice may be insulin-resistant (Fig. 4C) . These results are consistent with previous studies in Hnf1a À/À mice [12, 23] . In, addition, L-FABP1 was decreased in the livers of Hnf1a H-KO mice (Fig. 4D ), consistent with a previous study on HNF1a mutations [13] . Acetyl CoA carboxylase alpha (Acaca), sterol-regulatory element-binding protein 1c (SREBP1c), and peroxisome proliferator-activated receptor c (PPARc), which play important roles in fatty acid biosynthesis [24] [25] [26] , were upregulated during the steatotic and inflammatory phases (Fig. 4E) , indicating increased fatty acid synthesis in Hnf1a H-KO mice.
The livers of Hnf1a H-KO mice exhibit increased expression of inflammatory cytokines and activation of inflammatory and prosurvival signaling pathways
Inflammation is central to chronic hepatic impairment, and has been suggested as a risk factor for HCC [27] . Our previous work has demonstrated that downregulation of HNF1a stimulates the expression of the proinflammatory and profibrotic cytokines TNFa, TGFb1, and IL-6 in primary rat hepatocytes. These cytokines were therefore examined by IHC in Hnf1a H-KO mice. As expected, the expression of TNFa, TGFb1, and IL-6 gradually increased in Hnf1a H-KO mice from 10 to 70 weeks (Fig. 5A) , with more obvious staining in the cytoplasm of hepatocytes. We next isolated primary hepatocytes from 10-week-old Hnf1a H-KO mice. Consistent with the IHC results, the expression levels of TNFa, TGFb1, and IL-6 were significantly elevated in hepatocytes but not in nonhepatocytes (Fig. 5B) . To further examine the relationship between NAFLD-HCC and inflammation, we examined the activation of inflammation-related signaling pathways. Phosphorylation of the NF-jB subunit p65 and STAT3 in hepatocytes from 10-week-old Hnf1a H-KO mice were significantly increased compared to littermate control mice (Fig. 5C ), indicating activation of NF-jB and STAT3 signaling. Akt signaling plays important roles in cell survival and tumorigenesis [28] , and we also observed increased phosphorylation of Akt in Hnf1a H-KO hepatocytes. These results suggest that both inflammation-and survival-related signaling pathways were activated in the hepatocytes of Hnf1a H-KO mice.
Discussion
A number of studies suggest that NAFLD contributes to noncirrhotic HCC [4, 29, 30] , but the mechanisms leading to NAFLD-HCC are unknown. In this study, we established a mouse model with hepatocyte-specific knockout of HNF1a, and provide evidence that HNF1a deficiency leads to NAFLD-HCC.
HNF1a is well known for regulating glucose and lipid metabolism, but the role of HNF1a in NAFLD and NASH is unknown. We fed mice a HF diet to induce a mouse model of NAFLD, and observed reduced expression of HNF1a in fatty livers. It has been reported that Hnf1a whole body knockout mice develop several systemic diseases, such as Laron-type dwarfism and diabetes mellitus [23] . But this model is unable to illustrate the definite role of HNF1a in hepatocytes. With this report, Hnf1a hepatocyte-specific knockout mice displayed dyslipidemia and impaired blood glucose regulation without other systemic diseases. Moreover, no cirrhosis in HCC liver from Hnf1a H-KO mice was observed which is similar to the clinical performance of NAFLD-HCC patients. Hnf1a mutations are frequently detected in HCA, which is generally found in young women of childbearing age who have a long history of estrogen-based oral contraceptive use [20] . In this study, the HCC marker Gpc3 was elevated in the tumor nodules of Hnf1a H-KO mice, indicating that deletion of Hnf1a induced HCC rather than HCA. Therefore, this model is distinct from the HCC models induced by chemical reagents, and provides an ideal tool for the study of NAFLD-HCC.
Sterol-regulatory element-binding protein 1c is a transcription factor involved in cholesterol and fatty acid metabolism. Acaca, a limiting enzyme in the fatty acid synthesis process, is the downstream target gene of SREBP1c [25, 31, 32] . Our study showed that HNF1a deletion in hepatocytes led to the enhanced expression of SREBP1c and Acaca in the liver. Increased PPARc has been reported in the liver of obese patients with NAFLD and NASH, and its expression positively correlates with SREBP1c transcription level [33] . The increase of PPARc levels led to de novo lipogenesis and liver steatosis [34] . Our results demonstrated that the level of PPARc was remarkably increased by HNF1a deficiency. These data suggest that the synthesis of fatty acids in Hnf1a H-KO mice was increased. Interestingly, the expression of SREBP1c in HCC tissues is correlated with poor prognosis [35] , suggesting a connection between SREBP1c and HCC. Therefore, increased SREBP1c expression may participate in the progression of NAFLD-HCC in Hnf1a H-KO mice. Nonalcoholic steatohepatitis plays a major role in the development of HCC in fatty liver. The difference between simple reversible steatosis and NASH is the presence of inflammation [36] . It has been reported that liver lipid accumulation was substantially reduced in both IL6 À/À and TNFR1 À/À mice, indicating that both TNF and IL-6 contribute to the maintenance of hepatosteatosis [37] . Our results demonstrate that HNF1a deficiency resulted in lipid accumulation, which can lead to low-grade inflammatory response as the expression of both TNFa and IL-6 were elevated in the liver. These data suggest that the progression of NAFLD-HCC in Hnf1a H-KO mice is at least partly mediated by NASH.
The NF-jB, STAT3, and Akt pathways play critical roles in hepatocarcinogenesis [27, 38] . NF-jB can activate the expression of both TNFa and IL-6 [14] . IL-6 leads to hepatocellular activation of STAT3, an important molecule that transduces signals from numerous oncogenic proteins and pathways [39, 40] . In this study, we found that elevation of TNFa and IL-6 were accompanied by the activation of STAT3 and NF-jB in the livers of Hnf1a H-KO mice. This is consistent with our previous finding that inhibition of HNF1a in the liver promotes the release of TNFa and IL-6, and aggravates hepatic fibrosis induced by either chemical agents or surgical methods [14] . Moreover, TGFb1, and IL6 in hepatocytes and nonhepatocytes were detected by real-time PCR. (C) Western blot was used to detect the expression of HNF1a, p65, STAT3, and Akt signaling in hepatocytes from 10-week-old Hnf1a H-KO mice. n = 5 mouse in each group. *P < 0.05; **P < 0.01.
Akt signaling, which is important for cell survival and proliferation, was also significantly activated in Hnf1a H-KO mice. Thus, we speculate that the development of NAFLD-HCC induced by HNF1a deficiency may be partly attributed to the chronic inflammatory response mediated by inflammation and survival signaling pathways.
In conclusion, we have established a novel model for the study of fatty liver and HCC, and provided insight on the role of HNF1a in hepatocyte lipid accumulation and hepatocarcinogenesis. As we have previously illustrated the biological significance of HNF1a in fibrogenesis and HCC, this study adds more evidence that HNF1a is critical for the maintenance of hepatocyte homeostasis and presents as a potential therapeutic target for clinical treatment of chronic liver diseases and HCC.
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